The role of SOX2 in prostate cancer is well-established and it has been shown that SOX2 is one of the key drivers of lineage plasticity promoting drug resistance associated with aggressive forms of prostate cancer [10]. This evidence concerns the gene SOX2 and Familial prostate cancer.